We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Staining Methods for Malarial Blood Films Compared

By LabMedica International staff writers
Posted on 11 Jan 2015
Print article
Image: Photomicrograph of Plasmodium falciparum parasites in a blood film stained with Giemsa (Photo courtesy of the Centers for Disease Control and Prevention).
Image: Photomicrograph of Plasmodium falciparum parasites in a blood film stained with Giemsa (Photo courtesy of the Centers for Disease Control and Prevention).
Image: Photomicrograph of a peripheral blood smear stained with Leishman (Photo courtesy of Quazoo).
Image: Photomicrograph of a peripheral blood smear stained with Leishman (Photo courtesy of Quazoo).
Early parasitological diagnosis of malaria is the cornerstone of malaria treatment and control and although rapid diagnostic tests for malaria are increasingly used, microscopy remains the reference standard for malaria diagnosis.

In malaria-endemic regions, thin and thick smear preparation are used to diagnose malaria, but examination of the blood elements can also reveal other causes of fever including leukemia, or clues for viral infection or bacterial sepsis depending on the staining technique used.

Scientists at the Mahidol University (Bangkok, Thailand) working with an international team in India examined peripheral blood slides from 1,180 fever cases admitted to a local hospital from August to December 2012. A sample of 10 µL ethylenediaminetetraacetic acid (EDTA) treated blood was used for the simultaneous preparation of two thin and thick smear slides, one stained according to Giemsa and the other according to Leishman method.

After fixation the blood slides were stained with either Giemsa stain (Qualigen; Mumbai, India) or Leishman stain (S D Fine-Chem Ltd.; Mumbai, India). In both Giemsa- and Leishman-stained slides, the thick smear was used for diagnosis and quantitative assessment, whereas the thin smear for species identification. Parasitemia in all malaria positive cases was quantified per 200 white blood cells (WBC) independently by two microscopists.

In the blood films from the 1,180 fever patients that were compared according to staining method, 111 were identified as parasitemic using Giemsa and 110 with Leishman staining. There were 92 with Plasmodium falciparum, 2 with P. vivax, and 17 with co-infections of both of these parasites. A total of 276 patients showed other abnormalities including shift to the left with toxic granulation of neutrophils, atypical lymphocytes, suggestive of infectious mononucleosis, and a single case of acute lymphoblastic leukemia (ALL). The difference in parasitemia between methods increased with increased parasite density.

The authors concluded that the Leishman's staining method for thin and thick smears is a good alternative to Giemsa's stain for identifying Plasmodium parasites, however the Leishman method was superior for visualization of red and white blood cell morphology. The time taken for staining was shorter with the Leishman method, which can be an important advantage in countries such as India where diagnostic laboratories are sometimes understaffed. The study was published on December 30, 2014, in the Malaria Journal.

Related Links:

Mahidol University
Qualigen 
S D Fine-Chem Ltd.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.